Clinical Characteristics of Pruritus and Evaluation of Quality of Life in Patients With Bullous Pemphigoid

Whereas pruritus is a major symptom in bullous pemphigoid, its characteristics and its impact on quality of life have been little studied.

The objective of this study is to learn more about pruritus characteristics of patients with bullous pemphigoid, and in consequence to better understand the pathophysiology of pruritus, and then to better treat pruritus in this condition.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Bullous Pemphigoid Autoimmune Diseases Immune System Diseases Pathological Conditions, Signs and Symptoms Pemphigoid, Bullous Pruritus Signs and Symptoms Skin Diseases Skin Diseases, Vesiculobullous Skin Manifestations Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CH Argenteuil, Argenteuil, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

adult
pruriginous bullous pemphigoid lately diagnosed.
Without PB treatment
MMS (Mini Mental State Examination) ≥ 21
In hospitalization or consultation

Exclusion criteria

pregnant woman
nursing women

Treatment and study plan

Primary outcomes

Clinical characteristics of pruritus in patients with bullous pemphigoid

Time frame: Day1 ( when diagnosis of bullous pemphigoid is made)

Answers and scores in questionnaire about clinical characteristics of pruritus Demographics characteristics of patients Characteristics of the bullous pemphigoid

Secondary outcomes

Impact of pruritus on quality of life in patients with bullous pemphigoid

Time frame: Day 1 (when diagnosis of bullous pemphigoid is made )

Score 5D itch scale
Impact of pruritus on quality of life in patients with bullous pemphigoid

Time frame: Day1 (when diagnosis of bullous pemphigoid is made )

score ItchyQol (Itchy Quality of Life)
Impact of pruritus on quality of life in patients with bullous pemphigoid

Time frame: Day 1 (when diagnosis of bullous pemphigoid is made )

score ABQOL

Sponsors and collaborators

Lead sponsor

University Hospital, Brest

Other

Registry information

Acronym: PRURIPB

Important dates

Study start: 2017
Primary completion: 2018
Study completion: 2018
First posted: Sep 6, 2017
Registry last updated: Jan 7, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed